Patent · US Active

Anti-influenza virus pyrimidine derivative

US11725009B2 · kind B2 · utility

1Cited by

2References

17Claims

0Family size

Assignee

GUANGDONG RAYNOVENT BIOTECH CO., LTD. · CN

Inventors

Jian Xiong · Shanghai, CN
Chaofeng Long · Tangxia, CN
Jingjing Wang · Shanghai, CN
Xiaoxin Chen · Cupertino, US
Kevin X. Chen · Edison, US
Cheng Xie · Shanghai, CN
Peng Li · New York, US
Xuanjia Peng · Shanghai, CN
Jian Li · Shanghai, CN
Shuhui CHEN · Shanghai, CN

Key dates

Filing date	Aug 24, 2021
Grant date	Aug 15, 2023
Priority date	—
Expiry date	Aug 24, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/07
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention discloses a class of anti-influenza virus compounds, and the use thereof in the preparation of a drug for treating diseases associated with influenza viruses. In particular, the present invention discloses a compound represented by formula (I) and a pharmaceutically acceptable salt thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.